BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23901078)

  • 1. Genetic variation in IL18R1 and IL18 genes and Inteferon γ ELISPOT response to smallpox vaccination: an unexpected relationship.
    Ovsyannikova IG; Haralambieva IH; Kennedy RB; O'Byrne MM; Pankratz VS; Poland GA
    J Infect Dis; 2013 Nov; 208(9):1422-30. PubMed ID: 23901078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common SNPs/haplotypes in IL18R1 and IL18 genes are associated with variations in humoral immunity to smallpox vaccination in Caucasians and African Americans.
    Haralambieva IH; Ovsyannikova IG; Dhiman N; Kennedy RB; O'Byrne M; Pankratz VS; Jacobson RM; Poland GA
    J Infect Dis; 2011 Aug; 204(3):433-41. PubMed ID: 21742843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study.
    Ovsyannikova IG; Pankratz VS; Salk HM; Kennedy RB; Poland GA
    Hum Genet; 2014 Sep; 133(9):1083-92. PubMed ID: 24880604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smallpox vaccine, ACAM2000: Sites and duration of viral shedding and effect of povidone iodine on scarification site shedding and immune response.
    Pittman PR; Garman PM; Kim SH; Schmader TJ; Nieding WJ; Pike JG; Knight R; Johnston SC; Huggins JW; Kortepeter MG; Korman L; Ranadive M; Quinn X; Meyers MS
    Vaccine; 2015 Jun; 33(26):2990-6. PubMed ID: 25930115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between vaccinia-specific immune responses within a cohort of armed forces members.
    Umlauf BJ; Ovsyannikova IG; Haralambieva IH; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Viral Immunol; 2011 Oct; 24(5):415-20. PubMed ID: 21958369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human leukocyte antigen genotypes in the genetic control of adaptive immune responses to smallpox vaccine.
    Ovsyannikova IG; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    J Infect Dis; 2011 Jun; 203(11):1546-55. PubMed ID: 21592983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination.
    Haralambieva IH; Ovsyannikova IG; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
    Vaccine; 2011 Oct; 29(45):7883-95. PubMed ID: 21875636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
    Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
    J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of IL18 and IL18R1 polymorphisms: genetic susceptibility to knee osteoarthritis.
    Hulin-Curtis SL; Bidwell JL; Perry MJ
    Int J Immunogenet; 2012 Apr; 39(2):106-9. PubMed ID: 22136483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.
    Frey SE; Winokur PL; Salata RA; El-Kamary SS; Turley CB; Walter EB; Hay CM; Newman FK; Hill HR; Zhang Y; Chaplin P; Tary-Lehmann M; Belshe RB
    Vaccine; 2013 Jun; 31(29):3025-33. PubMed ID: 23664987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.
    Haralambieva IH; Ovsyannikova IG; Umlauf BJ; Vierkant RA; Shane Pankratz V; Jacobson RM; Poland GA
    Vaccine; 2011 Nov; 29(48):8988-97. PubMed ID: 21939710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenetics of smallpox vaccination.
    Stanley SL; Frey SE; Taillon-Miller P; Guo J; Miller RD; Koboldt DC; Elashoff M; Christensen R; Saccone NL; Belshe RB
    J Infect Dis; 2007 Jul; 196(2):212-9. PubMed ID: 17570108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with a codon-optimized A27L-containing plasmid decreases virus replication and dissemination after vaccinia virus challenge.
    Martínez O; Bravo Cruz A; Santos S; Ramírez M; Miranda E; Shisler J; Otero M
    Vaccine; 2017 Oct; 35(44):6007-6014. PubMed ID: 28629922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
    Trojan A; Rajeswaran R; Montemurro M; Mütsch M; Steffen R
    J Clin Virol; 2007 Sep; 40(1):80-3. PubMed ID: 17644471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulator-based enhancement of anti smallpox immune responses.
    Martínez O; Miranda E; Ramírez M; Santos S; Rivera C; Vázquez L; Sánchez T; Tremblay RL; Ríos-Olivares E; Otero M
    PLoS One; 2015; 10(4):e0123113. PubMed ID: 25875833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
    Treanor J; Wu H; Liang H; Topham DJ
    Vaccine; 2006 Nov; 24(47-48):6913-23. PubMed ID: 17014939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.
    Ovsyannikova IG; Salk HM; Larrabee BR; Pankratz VS; Poland GA
    Immunogenetics; 2015 Oct; 67(10):547-61. PubMed ID: 26329766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
    Pittman PR; Hahn M; Lee HS; Koca C; Samy N; Schmidt D; Hornung J; Weidenthaler H; Heery CR; Meyer TPH; Silbernagl G; Maclennan J; Chaplin P
    N Engl J Med; 2019 Nov; 381(20):1897-1908. PubMed ID: 31722150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.